SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-21-134419
Filing Date
2021-04-27
Accepted
2021-04-27 16:57:33
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 d124828d424b5.htm 424B5 351235
2 GRAPHIC g124828g11i11.jpg GRAPHIC 54741
3 GRAPHIC g124828g24k99.jpg GRAPHIC 53325
  Complete submission text file 0001193125-21-134419.txt   490072
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-254175 | Film No.: 21859774
SIC: 2834 Pharmaceutical Preparations